Early prostate cancer diagnosis by using artificial neural networks and support vector machines

Expert Systems with Applications

Volumn 36, Issue 3 PART 2, 2009, Pages 6357-6361

  Çinar, Murat ^a   Engin, Mehmet ^b   Engin, Erkan Zeki ^b   Ziya Atesci Y ^a  

^a Sifa Hastaneler Grubu   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Artificial neural network; Prostate cancer; Prostate specific antigen; Support vector machine

Indexed keywords

ANTIGENS; CLASSIFICATION (OF INFORMATION); DECISION MAKING; DIAGNOSIS; EXPERT SYSTEMS; HEALTH RISKS; MAPS; NEURAL NETWORKS; NONLINEAR PROGRAMMING; SUPPORT VECTOR MACHINES; UROLOGY;

BENIGN PROSTATIC HYPERPLASIA; BROYDEN-FLETCHER-GOLDFARB-SHANNO; LEVENBERG-MARQUARDT; PROSTATE ADENOCARCINOMAS; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; SCALED CONJUGATE GRADIENTS; TRAINING ALGORITHMS;

DISEASES;

EID: 58349121633     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2008.08.010     Document Type: Article

References (15)

1. Anagnostou T., Remzi M., Lykourinas M., and Djavan B. Artificial Neural Networks for decision-making in urologic oncology. European Urology 43 (2003) 596-603
2. Begg R.K., Palaniswami M., and Owen B. Support vector machines for automated gait classification. IEEE Transactions on Biomedical Engineering 52 (2005) 828-838
3. Gamito E.J., Crawford E.D., and Errejon A. Artificial neural networks for predictive modelling in prostate cancer. In: Mydlo J.H., and Godec J.C. (Eds). Prostate Cancer; Science and Clinical Practise (2003), Academic Press, San Diego 167-172
4. Joachims T. Making large-scale SVM learning practical to be published in advances in kernel methods - support vector learning (1998), MIT Press
5. Katton M.W., and Scardino P.T. Prediction of progression nomograms of clinical utility. Clinical Prostate Cancer 1 (2002) 90-96
6. Loeb S., Yu X., and Nadler R.B. Does body mass index affect outcomes following radical prostatectomy. Journal of Urology (2006) 175
7. Merseburger A.S., Connelly R.R., Sun L., Richter E., and Moul J.W. Se of serum creatinine to predict pathologic and recurrence among radical prostatectomy patients. Urology 58 5 (2001) 729-734
8. Moller M.F. A scale conjugate gradient algorithm for fast supervised learning. Neural Networks 6 (1993) 525-533
9. Partin A.W., Yoo J., Carter H.B., et al. The use of PSA clinical stage and Gleason score to predict pathological stage in men with localised prostate cancer. Journal of Urology 150 (1993) 110-114
10. Poulakis V., Witzsch U., Vries R., Emmerlich V., Meves M., Altmannsberger H.M., et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology 64 6 (2004) 1165-1170
11. Smaletz O., Scher M.O., Small E.J., et al. Nomogravn for overall survival of patients with progressive metastatic prostate cancer after castration. Journal of Clinical Oncology 20 (2002) 3972-3982
12. Stephan C., Meyer H.A., Kwiatkowski M., Recker F., Cammann H., Loening S.A., et al. A (-5, -7) proPSA based artificial neural network to detect prostate cancer. European Urology 50 5 (2006) 1014-1020
13. Subaşi A. Automatic recognition of alertness level from EEG by using neural network and wavelet coefficients. Expert Systems with Applications 28 (2005) 701-711
14. Wells D.M., and Niederer J. A medical expert system approach using artificial neural networks for standardized treatment planning. International Journal of Radiation Oncology Biology Physics 41 1 (1998) 173-182
15. Wingo P.A., Landus S., and Ries L.A. An adjustment to the 1997 estimate for new prostate cancer. Journal of Urology 80 (1997) 1810-1813